These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30204438)

  • 1. Manganese-Based Contrast Agents for Magnetic Resonance Imaging of Liver Tumors: Structure-Activity Relationships and Lead Candidate Evaluation.
    Wang J; Wang H; Ramsay IA; Erstad DJ; Fuchs BC; Tanabe KK; Caravan P; Gale EM
    J Med Chem; 2018 Oct; 61(19):8811-8824. PubMed ID: 30204438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.
    Erstad DJ; Ramsay IA; Jordan VC; Sojoodi M; Fuchs BC; Tanabe KK; Caravan P; Gale EM
    Invest Radiol; 2019 Nov; 54(11):697-703. PubMed ID: 31356382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Manganese Alternative to Gadolinium for MRI Contrast.
    Gale EM; Atanasova IP; Blasi F; Ay I; Caravan P
    J Am Chem Soc; 2015 Dec; 137(49):15548-57. PubMed ID: 26588204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism.
    Gale EM; Wey HY; Ramsay I; Yen YF; Sosnovik DE; Caravan P
    Radiology; 2018 Mar; 286(3):865-872. PubMed ID: 29117483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of Manganese(II)-Based Ethylenediaminetetraacetic Acid-Ethoxybenzyl Conjugate as a Highly Stable Hepatobiliary Magnetic Resonance Imaging Contrast Agent.
    Islam MK; Kim S; Kim HK; Kim YH; Lee YM; Choi G; Baek AR; Sung BK; Kim M; Cho AE; Kang H; Lee GH; Choi SH; Lee T; Park JA; Chang Y
    Bioconjug Chem; 2018 Nov; 29(11):3614-3625. PubMed ID: 30383368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron Emission Tomography-Magnetic Resonance Imaging Pharmacokinetics, In Vivo Biodistribution, and Whole-Body Elimination of Mn-PyC3A.
    Zhou IY; Ramsay IA; Ay I; Pantazopoulos P; Rotile NJ; Wong A; Caravan P; Gale EM
    Invest Radiol; 2021 Apr; 56(4):261-270. PubMed ID: 33136686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging.
    Aime S; Anelli L; Botta M; Brocchetta M; Canton S; Fedeli F; Gianolio E; Terreno E
    J Biol Inorg Chem; 2002 Jan; 7(1-2):58-67. PubMed ID: 11862541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel manganese chelated macromolecular MRI contrast agent based on O-carboxymethyl chitosan derivatives.
    Wang X; Xu L; Ren Z; Fan M; Zhang J; Qi H; Xu M
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110452. PubMed ID: 31473409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divalent Manganese Complexes as Potential Replacements for Gadolinium-Based Contrast Agents.
    Caravan P
    Invest Radiol; 2024 Feb; 59(2):187-196. PubMed ID: 38038701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese Complex of Ethylenediaminetetraacetic Acid (EDTA)-Benzothiazole Aniline (BTA) Conjugate as a Potential Liver-Targeting MRI Contrast Agent.
    Islam MK; Kim S; Kim HK; Park S; Lee GH; Kang HJ; Jung JC; Park JS; Kim TJ; Chang Y
    J Med Chem; 2017 Apr; 60(7):2993-3001. PubMed ID: 28301142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
    Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium Complex of 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic Acid (DO3A)-Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent.
    Baek AR; Kim HK; Park S; Lee GH; Kang HJ; Jung JC; Park JS; Ryeom HK; Kim TJ; Chang Y
    J Med Chem; 2017 Jun; 60(12):4861-4868. PubMed ID: 28530407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective encapsulation of a new cationic gadolinium chelate into apoferritin and its evaluation as an MRI contrast agent.
    Makino A; Harada H; Okada T; Kimura H; Amano H; Saji H; Hiraoka M; Kimura S
    Nanomedicine; 2011 Oct; 7(5):638-46. PubMed ID: 21333752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Manganese Chloride Tetrahydrate: A Novel Magnetic Resonance Liver Imaging Agent for Patients With Renal Impairment: Efficacy, Safety, and Clinical Implication.
    Brismar TB; Geisel D; Kartalis N; Madrazo BL; Persson Hedman H; Norlin A
    Invest Radiol; 2024 Feb; 59(2):197-205. PubMed ID: 37934630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
    Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL
    Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Janus Chelator Enables Biochemically Responsive MRI Contrast with Exceptional Dynamic Range.
    Gale EM; Jones CM; Ramsay I; Farrar CT; Caravan P
    J Am Chem Soc; 2016 Dec; 138(49):15861-15864. PubMed ID: 27960350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Manganese Porphyrin Platform for the Design and Synthesis of Molecular and Targeted MRI Contrast Agents.
    Vollett KDW; Szulc DA; Cheng HM
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mn(II)-Based MRI Contrast Agent Candidate for Vascular Imaging.
    Kálmán FK; Nagy V; Váradi B; Garda Z; Molnár E; Trencsényi G; Kiss J; Même S; Même W; Tóth É; Tircsó G
    J Med Chem; 2020 Jun; 63(11):6057-6065. PubMed ID: 32372648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.